Lymphoma
-
Forward Look
Immunotherapy in Advanced Hodgkin LymphomaPatients who received Opdivo and chemotherapy had better outcomes and fewer side effects than those who had the standard-of-care therapy.
by Susan Kreimer
-
Forward Look
Stem Cell Transplant Rates Decrease for LymphomaMore patients are receiving CAR T-cell therapy for large B-cell lymphoma.
by Leah Lawrence
-
Advocacy After LossFollowing her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Facts and Stats
From Lab Experiment to Lifesaving TreatmentDecades of research and clinical trials led to CAR T-cell therapy becoming a critical blood cancer treatment.
by Thomas Celona
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Living With Chronic Blood CancerThanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Q&A
Tangled Family TiesSusan Keller’s best hope at keeping cancer at bay meant tracking down a brother who didn’t want to be found.
by Marci A. Landsmann
-
Forward Look
Losing HeartCardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
by Marci A. Landsmann
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Survivor Profile
Control What You CanBusiness leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
